FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to pharmacology, and concerns an agent having an effect on cardiovascular system. The agent contains acetylsalicylic acid and succinic acid or its pharmaceutically acceptable salt in the ratio, weight parts: 1:20-20:1. The agent can be used for treatment of various forms of coronary heart disease (CHD), acute myocardial infarction, coronary insufficiency, cerebral ischemia, hypoxic stroke.
EFFECT: invention provides extended range of the agents possessing cardioprotective, antiarrhythmic and anti-ischemic action.
2 cl, 5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
| 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE SALTS SHOWING ANTIISCHEMIC, ANTIHYPOXIC AND ANTIARRHYTHMIC ACTIVITY AND 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE AS AN INTERMEDIATE PRODUCT FOR SYNTHESIS OF 2-[2-(DIETHYLAMINO) -ETHYLTHIO] -5,6-DIMETHYLBENZIMIDAZOLE SALTS | 1991 |
|
RU2027709C1 |
| METHOD OF BRAIN MITOCHONDRIA PREPARATION | 0 |
|
SU1745258A1 |
| COMBINED DRUG PREPARATION CARDIFOL EXHIBITING CARDIOPROTECTIVE, ANTIAGGREGANT AND ANTI-ISCHEMIC ACTION ON CARDIOVASCULAR SYSTEM | 2011 |
|
RU2446806C1 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| ORGANIC SALTS N1-(2,3,4-TRIMETHOXYBENZYL)-N2-{2-[(2,3,4-TRIMETHOXYBENZYL)AMINO]ETHYL}-1,2-ETHANE-DIAMINE | 2022 |
|
RU2813347C2 |
| MEDICINAL PREPARATION FOR CURING CEREBRAL ISCHEMIA | 1994 |
|
RU2108095C1 |
| AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
| METHOD FOR EVALUATING THE FUNCTIONAL STATE OF MITOCHONDRIA | 0 |
|
SU1668945A1 |
| CEREBROPROTECTING AGENT IN ENCEPHALOPATHY | 1998 |
|
RU2141330C1 |
